Efficient Enantioselective Formal Synthesis of Ro 67-8867, a NMDA 2B Receptor Antagonist

Ingrid Déchamps; Domingo Gomez Pardo; Phillipe Karoyan; Janine Cossy

doi:10.1055/s-2005-865225

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2005(7): 1170-1172
DOI: 10.1055/s-2005-865225

LETTER

Efficient Enantioselective Formal Synthesis of Ro 67-8867, a NMDA 2B Receptor Antagonist

Ingrid Déchamps^a, Domingo Gomez Pardo^a, Phillipe Karoyan^b, Janine Cossy*^a
^a Laboratoire de Chimie Organique associé au CNRS, Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI), 10 rue Vauquelin, 75231 Paris Cedex 05, France
^b UMR, CNRS 7613, Structure et Fonction de Molécules Bioactives, Université Paris VI, case 45, 4 place Jussieu, 75252 Paris Cedex 05, France
Fax: +33(1)40794660; e-Mail: janine.cossy@espci.fr;

Further Information

Publication History

Received 2 February 2005
Publication Date:
14 April 2005 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

An efficient enantioselective formal synthesis of Ro 67-8867 has been achieved in 7 steps using an amino-zinc-ene-enolate cyclization and an enantioselective ring enlargement of a substituted prolinol as the key steps.

Key words

amino-zinc-ene-enolate cyclization - asymmetric synthesis - ring expansion - piperidines - prolinol

References

1a Grauert M. Bechtel WD. Ensinger HA. Merz H. Carter AJ. J. Med. Chem. 1997, 40: 2922

Crossref Google Scholar
1b Guzikowski AP. Whittemore ER. Woodward RM. Weber E. Keana JFW. J. Med. Chem. 1997, 40: 2424

Crossref Google Scholar
1c Gee KR. Niu L. Schaper K. Jayaraman V. Hess G. Biochemistry 1999, 38: 3140

Crossref Google Scholar
2a Alanine A, Burner S, Buettelmann B, Heitz Neidhart M.-P, Jaeschke G, Pinard E, and Wyler R. inventors; WO 0075109. ; Chem. Abstr. 2000, 134, 42064

Crossref
2b Crameri Y, Scalone M, Waldmeier P, and Widmer U. inventors; EP 1136475. ; Chem. Abstr. 2001, 135, 272882

Crossref
2c Alanine A, Buettelmann B, Fisher H, Huwyler J, Heitz Neidhart M.-P, Jaeschke G, Pinard E, and Wyler R. inventors; WO 0216321. ; Chem. Abstr. 2002, 136, 216649

Crossref
2d Scalone M. Waldmeier P. Org. Process Res. Dev. 2003, 7: 418

Crossref Google Scholar
3a Karoyan P. Chassaing G. Tetrahedron Lett. 1997, 38: 85

Crossref PubMed Google Scholar
3b Lorthiois E. Marek I. Normant J. Tetrahedron Lett. 1997, 38: 89

Crossref PubMed Google Scholar
3c Karoyan P. Chassaing G. Tetrahedron: Asymmetry 1997, 8: 2025

Crossref PubMed Google Scholar
3d Lorthiois E. Marek I. Normant J. J. Org. Chem. 1998, 63: 2442

Crossref PubMed Google Scholar
3e Karoyan P. Chassaing G. Tetrahedron Lett. 2002, 43: 253

Crossref PubMed Google Scholar
3f Karoyan P. Chassaing G. Tetrahedron Lett. 2002, 43: 1221

Crossref PubMed Google Scholar
3g Karoyan P. Quancard J. Vaissermann J. Chassaing G. J. Org. Chem. 2003, 68: 2256

Crossref PubMed Google Scholar
3h Quancard J. Magellan H. Lavielle S. Chassaing G. Karoyan P. Tetrahedron Lett. 2004, 45: 2185

Crossref PubMed Google Scholar
3i Quancard J. Labonne A. Jacquot Y. Chassaing G. Lavielle S. Karoyan P. J. Org. Chem. 2004, 69: 7940

Crossref PubMed Google Scholar
For comprehensive reviews, see:
4a Cossy J. Gomez Pardo D. Chemtracts 2002, 15: 579

Google Scholar
4b Cossy J. Gomez Pardo D. Targets in Heterocyclic Systems 2002, 6: 1

Google Scholar
8a Cossy J. Dumas C. Michel P. Gomez Pardo D. Tetrahedron Lett. 1995, 36: 549

Crossref Google Scholar
8b Cossy J. Dumas C. Gomez Pardo D. Synlett 1997, 905

Crossref Google Scholar
8c Cossy J. Dumas C. Gomez Pardo D. Bioorg. Med. Chem. Lett. 1997, 7: 1343

Crossref Google Scholar
8d Wilken J. Kossenjans M. Saak W. Haase D. Pohl S. Martens J. Liebigs Ann. 1997, 573

Crossref Google Scholar
8e Langlois N. Calvez O. Synth. Commun. 1998, 28: 4471

Crossref Google Scholar
8f Davis PW. Osgood SA. Hébert N. Sprankle KG. Swayze EE. Biotechnol. Bioeng. 1999, 61: 143

Crossref Google Scholar
8g Cossy J. Dumas C. Gomez Pardo D. Eur. J. Org. Chem. 1999, 1693

Crossref Google Scholar
8h Michel P. Rassat A. J. Org. Chem. 2000, 65: 2572

Crossref Google Scholar
8i Cossy J. Mirguet O. Gomez Pardo D. Synlett 2001, 1575

Crossref Google Scholar
8j Brandi A. Cicchi S. Paschetta V. Gomez Pardo D. Cossy J. Tetrahedron Lett. 2002, 43: 9357

Crossref Google Scholar
8k Deyine A. Delcroix J.-M. Langlois N. Heterocycles 2004, 64: 207

Crossref Google Scholar

5

Analytical Data.
Compound 5: [α]_D ²⁰ +39.2 (c 1.4, CHCl₃). IR (neat): 2962, 1724, 1491, 1450, 1371, 1160, 1089, 1026, 769, 740, 706 cm^-1. ¹H NMR: δ = 7.23-7.02 (m, 10 H), 4.06 (m, 2 H), 3.64 (q, J = 6.8 Hz, 1 H), 3.36 (d, J = 7.9 Hz, 1 H), 2.97 (dt, J = 8.3, 3.4 Hz, 1 H), 2.80-2.69 (m, 2 H), 2.54 (m, 1 H), 2.23 (dd, J = 13.2, 10.6 Hz, 1 H), 1.75-1.61 (m, 2 H), 1.29 (d, J = 6.8 Hz, 3 H), 1.15 (t, J = 7.2 Hz, 3 H). ¹³C NMR: δ = 173.4 (s), 144.5 (s), 140.5 (s), 128.6 (d), 128.3 (d), 128.2 (d), 127.5 (d), 127.1 (d), 126.0 (d), 66.7 (d), 61.8 (d), 59.9 (t), 50.2 (t), 43.7 (d), 37.1 (t), 29.7 (t), 22.7 (q), 14.3 (q). MS (EI): m/z (relative intensity) = 337 (1) [M⁺], 265 (23), 264 (100), 143 (4), 106 (5), 105 (56), 104 (3), 103 (6), 91 (19), 79 (7), 77 (6), 68 (5).

6

Compound 5 was the only product detected by ¹H NMR and GC-MS.

7

Analytical Data.
Compound 6: [α]_D ²⁰ +8.6 (c 4.3, CHCl₃). IR (neat): 3420, 3015, 2920, 1600, 1485, 1445, 1370, 1310, 1155, 1080, 1025, 765, 745, 705, 700 cm^-1. ¹H NMR: δ = 7.28-7.14 (m, 7 H), 7.13-7.05 (m, 3 H), 3.72 (q, J = 6.8 Hz, 1 H), 3.54 (dd, J = 10.9, 3.02 Hz, 1 H), 3.46 (dd, J = 11.1, 4.1 Hz, 1 H), 3.04 (m, 1 H), 2.86-2.73 (m, 2 H), 2.60 (m, 1 H), 2.32-2.15 (m, 2 H), 1.54-1.40 (m, 2 H), 1.36 (d, J = 6.8 Hz, 3 H).
¹³C NMR: δ = 143.5 (s), 141.2 (s), 128.6 (d), 128.4 (d), 128.4 (d), 127.7 (d), 127.2 (d), 125.9 (d), 62.6 (d), 62.2 (d), 60.4 (t), 50.8 (t), 43.1 (d), 36.2 (t), 31.3 (t), 22.3 (q). MS (EI): m/z (relative intensity): 295 (1) [M⁺], 280 (5), 265 (22), 264 (100), 161 (8), 160 (66), 143 (6), 106 (8), 105 (79), 103(8), 91 (27), 79 (10), 77 (9), 68 (7).

9

Analytical Data.
Compound 7: [α]_D ²⁰ -24.6 (c 1.1, CHCl₃). IR (neat): 3492, 3009, 2910, 2798, 1600, 1491, 1451, 1395, 1210, 1095, 1060, 762, 709 cm^-1. ¹H NMR: δ = 7.27-7.13 (m, 7 H), 7.12-7.05 (m, 3 H), 3.55-3.40 (m, 2 H), 2.99 (m, 1 H), 2.90-2.80 (m, 1 H), 2.76-2.64 (m, 2 H), 2.45 (dd, J = 13.2, 6.4 Hz, 1 H), 1.98 (m, 1 H), 1.80 (m, 1 H), 1.54-1.31 (m, 3 H), 1.28 (d, J = 6.8 Hz, 3 H). ¹³C NMR: δ = 143.0 (s), 140.8 (s), 129.2 (d), 128.3 (d), 128.2 (d), 127.6 (d), 127.1 (d), 125.7 (d), 66.7 (d), 63.6 (d), 56.5 (t), 50.6 (t), 42.6 (d), 38.8 (t), 26.9 (t), 18.4 (q). MS (EI): m/z (relative intensity) = 295 (11) [M⁺], 281 (23), 280 (100), 218 (14), 190 (6), 105 (32), 103 (4), 91 (18), 79 (5), 77 (5).

10

Analytical Data.
Compound 8: [α]_D ²⁰ -36.6 (c 1, CHCl₃). IR (neat): 3290, 2915, 1604, 1532, 1452, 1282, 1263, 1110, 1001, 848, 753, 706 cm^-1. ¹H NMR: δ = 7.24-7.07 (m, 5 H), 3.52-3.46 (m, 1 H), 2.99-2.86 (m, 2 H), 2.68 (d, J = 13.6, 7.5 Hz, 1 H), 2.58-2.47 (m, 5 H), 1.65-1.27 (m, 3 H). ¹³C NMR: δ = 140.6 (s), 129.2 (d), 128.2 (d), 125.8 (d), 66.3 (d), 53.1 (t), 46.5 (t), 42.6 (d), 39.3 (t), 27.2 (t). MS (EI): m/z (relative intensity) = 191 (100) [M⁺], 162 (9), 147 (8), 131 (7), 118 (32), 115 (13), 100 (20), 92 (11), 91 (67), 82 (22), 77 (11), 72 (11), 71 (42), 65 (22), 57 (30), 56 (30), 55 (26).